| Dr Randall Matthew Willis, MD | |
|
207 Brechin Ln, Knoxville, TN 37909-2165 | |
| (865) 406-4044 | |
| Not Available |
| Full Name | Dr Randall Matthew Willis |
|---|---|
| Gender | Male |
| Speciality | Preventive Medicine - Sports Medicine |
| Location | 207 Brechin Ln, Knoxville, Tennessee |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053569145 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2083S0010X | Preventive Medicine - Sports Medicine | 14380 (Tennessee) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Randall Matthew Willis, MD 5508 Kingston Pike, Suite 150, Knoxville, TN 37919-5048 Ph: (865) 584-6464 | Dr Randall Matthew Willis, MD 207 Brechin Ln, Knoxville, TN 37909-2165 Ph: (865) 406-4044 |
News Archive
Hypertension, or high blood pressure, is the leading risk factor for heart disease, and improvements in both targeted and population-based strategies for blood pressure control can lead to better prevention and control of hypertension, according to a review paper published today in the Journal of the American College of Cardiology.
A leading immunology research institute has validated the long-held and controversial hypothesis that antibodies - usually the "good guys" in the body's fight against viruses - instead contribute to severe dengue virus-induced disease, the La Jolla Institute for Allergy & Immunology announced today. The finding has major implications for the development of a first-ever vaccine against dengue virus, a growing public health threat which annually infects 50 to 100 million people worldwide, causing a half million cases of the severest form.
Virginia Commonwealth University researchers studying the enzyme that triggers inflammation have found that it may be a target for a new class of anti-inflammatory drugs to treat arthritis, asthma, multiple sclerosis, lung and colon cancers and Alzheimer's disease.
Agenta Biotechnologies, Inc., a private biotechnology company, announced that it has received a $1.1 million grant from the National Institutes of Health and National Institute of Dental and Craniofacial Research (NIH/NIDCR) for the further development of a biologically activated membrane to improve soft tissue healing associated with oral surgery.
A new understanding of the initial interactions of human immunodeficiency virus type 1 (HIV-1) and dendritic cells is described by Boston University School of Medicine (BUSM) researchers in a study currently featured in the Proceedings of the National Academy of Sciences.
› Verified 8 days ago
Dr. Jennifer Lynn Anderson, M.D. Preventive Medicine Medicare: May Accept Medicare Assignments Practice Location: 2805 W Governor John Sevier Hwy, Knoxville, TN 37920 Phone: 865-298-3558 | |
Paul Michael Mccurry, MD Preventive Medicine Medicare: Accepting Medicare Assignments Practice Location: 2014 Still Water Ln, Knoxville, TN 37922 Phone: 615-300-5775 | |
Laykoon Tan Huang, MD MPH Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 108 W Inskip Dr, Suite B, Knoxville, TN 37912 Phone: 865-687-2277 Fax: 865-689-5336 | |
Dana Kay Webber, APRN, FNP-C Preventive Medicine Medicare: Accepting Medicare Assignments Practice Location: 9221 Middlebrook Pike, Ste 102, Knoxville, TN 37931 Phone: 865-219-1989 Fax: 865-409-5974 | |
Anne Sanchez Roberts, MD Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 1924 Alcoa Hwy, Knoxville, TN 37920 Phone: 865-544-9352 | |
Joseph E Rich, M.D. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 9217 Park West Blvd Ste E1, Knoxville, TN 37923 Phone: 865-694-9553 |